Skip to main content
. 2020 Sep 14;7:1233–1241. doi: 10.1016/j.toxrep.2020.09.006

Table 2.

Results of in vitro micronucleus test with Dry Mankai in TK6 cells.

Treatment Short-term treatment
Continuous treatment
Treatment time (h) 4
4
24
Metabolic activation -S9
+S9
-S9
Concentration of test article (μg/mL) RPD (%) Cells with micronucleus (%) RPD (%) Cells with micronucleus (%) RPD (%) Cells with micronucleus (%)
 Negative controla 100 0.6 100 0.7 100 0.6
 62.5 NE 89 NO NE
 125 NE 84 NO NE
 250 86 NO 72 0.9 99 0.6
 500 77 NO 68 0.9 102 0.6
 750 81 0.7 41 0.8 NE
 1000 59 0.7 38 NO 100 0.6
 1250 44 0.9 NE NE
 1500 −13 NO NE NE
 2000 NE NE 103 0.7
 Positive control b, c NE 49 1.9* 68 4.0*

Significantly different from the negative control by Fisher’s exact test: * p < 0.05.

RPD, Relative population doubling; NE, Not examined; NO, Not observed.

a

Water for injection.

b

Cyclophosphamide (1.5 μg/mL) in Short-term treatment with S9 mix.

c

Colchicine (0.006 μg/mL) in Continuous treatment.